InvestorsHub Logo
Followers 183
Posts 19312
Boards Moderated 0
Alias Born 03/07/2009

Re: Klinsmann post# 303

Tuesday, 03/21/2017 6:30:24 PM

Tuesday, March 21, 2017 6:30:24 PM

Post# of 398
This still has $6 per share in cash value even after taking into account termination costs, right?

If not acquired, it will make a great reverse merger candidate for a private pharma / biotech company.